Learn more

COY DAVID HOWARD

Overview
  • Total Patents
    71
About

COY DAVID HOWARD has a total of 71 patent applications. Its first patent ever was published in 1977. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are RORER BIOTECHNOLOGY, MITTENZWEI HELLMUT and CHILDRENS HOSP RES FOUNDATION.

Patent filings per year

Chart showing COY DAVID HOWARDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Coy David H 42
#2 Kastin Abba J 28
#3 Coy David Howard 12
#4 Kastin Abba Jeremiah 5
#5 Schally Andrew Victor 4
#6 Schally Andrew V 4
#7 Maderdrut Jerome L 2
#8 Li Min 2
#9 Debitsudo Hawaado Koi 2
#10 Rajeswaran Walajapet G 2

Latest patents

Publication Filing date Title
IE822928L Peptides
ZA8209041B Lh-rh antagonists
AU9102582A Lh-rh antagonists
US4431635A LH-RH Antagonists
AU7658481A Anorexigenic tripeptodes
CA1181395A Lh-rh antagonists
US4317815A LH-RH Antagonists
US4180501A Bis (polypeptide) derivatives of enkephalin
AU3710778A Polypeptides
US4213968A Enkephalin derivatives
PT66982A Process for preparing novel methionine enkephalin derivatives
GB1592385A Methionine enkephalin derivatives
US4127523A Novel undecapeptides, intermediates therefor, and compositions and methods employing said undecapeptides
US4127527A Novel pentadecapeptides, intermediates therefor, and compositions and methods employing said pentadecapeptides
US4139504A Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
US4127520A Novel nonadecapeptides, intermediates therefor, and compositions and methods employing said nonadecapeptides
US4127521A Novel octacosapeptides, intermediates therefor and pharmaceutical compositions and methods employing said octacosapeptides
US4127528A Novel derivatives of alpha-endorphin, intermediates therefor and compositions and methods employing said derivatives
US4127518A Novel derivatives of gamma-endorphins, intermediates therefor, and compositions and methods employing said derivatives
US4127524A Novel dodecapeptides, intermediates therefor, and compositions and methods employing said dodecapeptides